MedPath
FDA Approval

PANRETIN

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
August 18, 2021
Labeling Type
Human Prescription Drug Label
Alitretinoin(60 mg in 60 g)

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

PANRETIN

Product Details

NDC Product Code
59212-601
Application Number
NDA020886
Marketing Category
NDA (C73594)
Route of Administration
TOPICAL
Effective Date
September 10, 2019
Code: 1UA8E65KDZClass: ACTIBQuantity: 60 mg in 60 g
POLYETHYLENE GLYCOL 400Inactive
Code: B697894SGQClass: IACT
HYDROXYPROPYL CELLULOSEInactive
Code: RFW2ET671PClass: IACT
ALCOHOLInactive
Code: 3K9958V90MClass: IACT
BUTYLATED HYDROXYTOLUENEInactive
Code: 1P9D0Z171KClass: IACT
© Copyright 2025. All Rights Reserved by MedPath